ARTICLE | Clinical News
Proteosome influenza vaccine: Phase I
April 30, 2001 7:00 AM UTC
Intellivax International Inc., Montreal, Quebec Product: Proteosome influenza vaccine Business: Infectious diseases Therapeutic category: Immune stimulation, Viral infection Target: Immune cells Descr...